<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01517750</url>
  </required_header>
  <id_info>
    <org_study_id>FPH-OSA-TS-2012</org_study_id>
    <nct_id>NCT01517750</nct_id>
  </id_info>
  <brief_title>Study to Predict the Need for Humidification Use and Comparison of the Effect of ThermoSmart™ and no Humidification on Adherence</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helios Klinik Ambrock</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the effectiveness of continuous positive airway pressure (CPAP) in abolishing upper
      airway obstruction, acceptance of and adherence with therapy has been sub-optimal. One of the
      only technological advancements shown to increase adherence is heated humidification, now
      considered part of conventional CPAP therapy in some countries. ThermoSmart™ is a unique
      technology developed by Fisher &amp; Paykel Healthcare which utilises a heated breathing tube to
      deliver optimal humidity in all environments. ThermoSmart has been shown to be superior to
      conventional humidification in reducing side effects, condensation and titrated pressure as
      well as increasing total sleep time. However, improved humidity delivery has not lead to
      significantly increased adherence in unselected obstructive sleep apnea (OSA) patients.

      A total of 80 patients diagnosed with OSA but naive to CPAP use will be randomized into a
      single blind, randomized, parallel-arm trial to determine whether the the use of heated
      humidification will impact therapy adherence.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapy Adherence With Treatment Per Night Averaged Over Total Time Period Measured Via Internal Software on the Device and Reported on Using InfoSmart™ Software With and Without Heated Humidification.</measure>
    <time_frame>6 weeks after patient randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Score (ESS)</measure>
    <time_frame>6 weeks after patient randomization</time_frame>
    <description>The ESS is a measure of daytime sleepiness and has a total of 24 points. A range from 0-9 is considered normal. A score of more than 9 is considered to have abnormal daytime sleepiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Outcome of Sleep Questionnaire (FOSQ)</measure>
    <time_frame>6 weeks after patient randomization</time_frame>
    <description>FOSQ is a measure of the impact of the disorder on multiple activities with everyday living and how the treatment can improve these activities. There are 30 questions and for each questions you have to pick from a subscale from 0-4; 0 = &quot;I don't do this activity for other reasons&quot;, 1=&quot;Yes extremely&quot;, 2=&quot;Yes moderately&quot;, 3= &quot;Yes a little&quot;, 4 = &quot;No&quot;. Scores of each subscale will be summed up and scaled to a maximum achievable value of 20. The sum score was calculated. The value range is 0-100. A higher score means that the treatment has positively improved everyday activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasopharyngeal Complaints</measure>
    <time_frame>6 weeks after patient randomization</time_frame>
    <description>Nasopharyngeal complaints (NPC) were assessed by a questionnaire. Subjects were asked to evaluate their condition on a scale from 0 (&quot;no complaints&quot;) to 5 (&quot;very strong&quot;). The following questions were asked within the questionnaire: Did you observe nasal congestion, nasal dryness, runny nose, dry mouth, and dry throat (0-5 each) during the last week. The maximal achievable sum score was 25.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <arm_group>
    <arm_group_label>APAP with humidification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICON Auto CPAP™ with Thermosmart heated tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>APAP without humidification</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ICON Auto CPAP™ without Thermosmart heated tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICON Auto CPAP™ with Thermosmart heated tube</intervention_name>
    <description>ICON Auto CPAP™ with heated humidification and the use of a heated tube</description>
    <arm_group_label>APAP with humidification</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICON Auto CPAP™ without Thermosmart heated tube</intervention_name>
    <description>ICON Auto CPAP™ without heated humidification or the use of a heated tube.</description>
    <arm_group_label>APAP without humidification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with OSA

          -  Naïve to CPAP therapy, i.e have not been prescribed, or used CPAP in the last 5 years

          -  Prescribed a nasal mask (as patients will be prescribed their mask following
             recruitment into the study, any participants who are prescribed a full face mask will
             be withdrawn)

        Exclusion Criteria:

          -  Severe heart disease

          -  Co-existing lung disease

          -  Co-existing sleep disorders

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Nilius, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Klinik Ambrock</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helios - Klinik Ambrock</name>
      <address>
        <city>Hagen</city>
        <state>Weg</state>
        <zip>60</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.fphcare.co.nz/</url>
    <description>Sponsor Site</description>
  </link>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2012</study_first_submitted>
  <study_first_submitted_qc>January 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2012</study_first_posted>
  <results_first_submitted>March 10, 2015</results_first_submitted>
  <results_first_submitted_qc>June 21, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 24, 2015</results_first_posted>
  <last_update_submitted>June 21, 2015</last_update_submitted>
  <last_update_submitted_qc>June 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Humidification</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <keyword>ICON</keyword>
  <keyword>ThermoSmart</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunoconjugates</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>APAP Without Humidification + Low RIsks of NPC</title>
          <description>ICON Auto CPAP™ (continuous positive airway pressure) without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints classified as a NPC score equal or less than 9) of nasopharyngeal problems.</description>
        </group>
        <group group_id="P2">
          <title>APAP With Humidification + Low Risks of NPC</title>
          <description>ICON Auto CPAP™ (continuous positive airway pressure) with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints classified as a NPC score equal or less than 9) of nasopharyngeal problems.</description>
        </group>
        <group group_id="P3">
          <title>APAP With Humidification + High Risks of NPC</title>
          <description>ICON Auto CPAP™ (continuous positive airway pressure) with Thermosmart heated tube with patients who are classified to have a high risks (major complaints classified as a NPC score more than 9) of nasopharyngeal problems.</description>
        </group>
        <group group_id="P4">
          <title>APAP Without Humidification + High RIsks of NPC</title>
          <description>ICON Auto CPAP™ (continuous positive airway pressure) without Thermosmart heated tube with patients who are classified to have a high risks (major complaints classified as a NPC score more than 9) of nasopharyngeal problems.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>APAP With Humidification + Low Risks of NPC</title>
          <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="B2">
          <title>APAP Without Humidification + Low RIsks of NPC</title>
          <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="B3">
          <title>APAP With Humidification + High Risks of NPC</title>
          <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="B4">
          <title>APAP Without Humidification + High Risks of NPC</title>
          <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="17"/>
            <count group_id="B4" value="18"/>
            <count group_id="B5" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.6" spread="9.8"/>
                    <measurement group_id="B2" value="54.3" spread="8.8"/>
                    <measurement group_id="B3" value="50.9" spread="6.8"/>
                    <measurement group_id="B4" value="52.1" spread="8.7"/>
                    <measurement group_id="B5" value="52.3" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Therapy Adherence With Treatment Per Night Averaged Over Total Time Period Measured Via Internal Software on the Device and Reported on Using InfoSmart™ Software With and Without Heated Humidification.</title>
        <time_frame>6 weeks after patient randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>APAP With Humidification + Low Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O2">
            <title>APAP Without Humidification + Low RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O3">
            <title>APAP With Humidification + High Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O4">
            <title>APAP Without Humidification + High RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Therapy Adherence With Treatment Per Night Averaged Over Total Time Period Measured Via Internal Software on the Device and Reported on Using InfoSmart™ Software With and Without Heated Humidification.</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="330" spread="116"/>
                    <measurement group_id="O2" value="321" spread="89"/>
                    <measurement group_id="O3" value="330" spread="103"/>
                    <measurement group_id="O4" value="281" spread="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Epworth Sleepiness Score (ESS)</title>
        <description>The ESS is a measure of daytime sleepiness and has a total of 24 points. A range from 0-9 is considered normal. A score of more than 9 is considered to have abnormal daytime sleepiness</description>
        <time_frame>6 weeks after patient randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>APAP With Humidification + Low Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O2">
            <title>APAP Without Humidification + Low RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O3">
            <title>APAP With Humidification + High Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O4">
            <title>APAP Without Humidification + High RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Epworth Sleepiness Score (ESS)</title>
          <description>The ESS is a measure of daytime sleepiness and has a total of 24 points. A range from 0-9 is considered normal. A score of more than 9 is considered to have abnormal daytime sleepiness</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="5.0"/>
                    <measurement group_id="O2" value="4.9" spread="4.9"/>
                    <measurement group_id="O3" value="5.7" spread="3.5"/>
                    <measurement group_id="O4" value="9.1" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Functional Outcome of Sleep Questionnaire (FOSQ)</title>
        <description>FOSQ is a measure of the impact of the disorder on multiple activities with everyday living and how the treatment can improve these activities. There are 30 questions and for each questions you have to pick from a subscale from 0-4; 0 = &quot;I don't do this activity for other reasons&quot;, 1=&quot;Yes extremely&quot;, 2=&quot;Yes moderately&quot;, 3= &quot;Yes a little&quot;, 4 = &quot;No&quot;. Scores of each subscale will be summed up and scaled to a maximum achievable value of 20. The sum score was calculated. The value range is 0-100. A higher score means that the treatment has positively improved everyday activities.</description>
        <time_frame>6 weeks after patient randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>APAP With Humidification + Low Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O2">
            <title>APAP Without Humidification + Low RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O3">
            <title>APAP With Humidification + High Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O4">
            <title>APAP Without Humidification + High RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Outcome of Sleep Questionnaire (FOSQ)</title>
          <description>FOSQ is a measure of the impact of the disorder on multiple activities with everyday living and how the treatment can improve these activities. There are 30 questions and for each questions you have to pick from a subscale from 0-4; 0 = &quot;I don't do this activity for other reasons&quot;, 1=&quot;Yes extremely&quot;, 2=&quot;Yes moderately&quot;, 3= &quot;Yes a little&quot;, 4 = &quot;No&quot;. Scores of each subscale will be summed up and scaled to a maximum achievable value of 20. The sum score was calculated. The value range is 0-100. A higher score means that the treatment has positively improved everyday activities.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.7" spread="7.6"/>
                    <measurement group_id="O2" value="91.7" spread="14.8"/>
                    <measurement group_id="O3" value="90.0" spread="11.9"/>
                    <measurement group_id="O4" value="82.0" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nasopharyngeal Complaints</title>
        <description>Nasopharyngeal complaints (NPC) were assessed by a questionnaire. Subjects were asked to evaluate their condition on a scale from 0 (“no complaints”) to 5 (“very strong&quot;). The following questions were asked within the questionnaire: Did you observe nasal congestion, nasal dryness, runny nose, dry mouth, and dry throat (0-5 each) during the last week. The maximal achievable sum score was 25.</description>
        <time_frame>6 weeks after patient randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>APAP With Humidification + Low Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O2">
            <title>APAP Without Humidification + Low RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O3">
            <title>APAP With Humidification + High Risks of NPC</title>
            <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
          <group group_id="O4">
            <title>APAP Without Humidification + High RIsks of NPC</title>
            <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
          </group>
        </group_list>
        <measure>
          <title>Nasopharyngeal Complaints</title>
          <description>Nasopharyngeal complaints (NPC) were assessed by a questionnaire. Subjects were asked to evaluate their condition on a scale from 0 (“no complaints”) to 5 (“very strong&quot;). The following questions were asked within the questionnaire: Did you observe nasal congestion, nasal dryness, runny nose, dry mouth, and dry throat (0-5 each) during the last week. The maximal achievable sum score was 25.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="4.4"/>
                    <measurement group_id="O2" value="7.3" spread="3.1"/>
                    <measurement group_id="O3" value="5.4" spread="3.0"/>
                    <measurement group_id="O4" value="10.7" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Outcomes in Patients With ENT (Ears, Nose and Throat) Surgeries</title>
        <time_frame>6 weeks after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Previous ENT Surgeries + Humidification</title>
          </group>
          <group group_id="O2">
            <title>Previous ENT Surgeries + Without Humidification</title>
          </group>
          <group group_id="O3">
            <title>Without Previous ENT Surgeries + Humidification</title>
          </group>
          <group group_id="O4">
            <title>WIthout Previous ENT Surgeries + WIthout Humidification</title>
          </group>
        </group_list>
        <measure>
          <title>Outcomes in Patients With ENT (Ears, Nose and Throat) Surgeries</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NPC (Nasopharyngeal complaints)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="4.7"/>
                    <measurement group_id="O2" value="10.8" spread="6.1"/>
                    <measurement group_id="O3" value="4.9" spread="3.0"/>
                    <measurement group_id="O4" value="7.5" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ESS (Epworth sleepiness score)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="5.7"/>
                    <measurement group_id="O2" value="8.1" spread="4.9"/>
                    <measurement group_id="O3" value="5.5" spread="3.2"/>
                    <measurement group_id="O4" value="6.5" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FOSQ (Functional outcome of sleep questionnaire</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" spread="15.9"/>
                    <measurement group_id="O2" value="85.5" spread="12.1"/>
                    <measurement group_id="O3" value="90.9" spread="11.5"/>
                    <measurement group_id="O4" value="88.5" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Adherence With ENT Surgeries</title>
        <time_frame>6 weeks after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Previous ENT Surgeries + Humidification</title>
          </group>
          <group group_id="O2">
            <title>Previous ENT Surgeries + Without Humidification</title>
          </group>
          <group group_id="O3">
            <title>Without Previous ENT Surgeries + Humidification</title>
          </group>
          <group group_id="O4">
            <title>WIthout Previous ENT Surgeries + WIthout Humidification</title>
          </group>
        </group_list>
        <measure>
          <title>Adherence With ENT Surgeries</title>
          <units>mins</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="327.9" spread="121.1"/>
                    <measurement group_id="O2" value="285.6" spread="124.6"/>
                    <measurement group_id="O3" value="331.5" spread="102.2"/>
                    <measurement group_id="O4" value="317.0" spread="82.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>APAP With Humidification + Low Risks of NPC</title>
          <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="E2">
          <title>APAP Without Humidification + Low RIsks of NPC</title>
          <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a low risks (minor complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="E3">
          <title>APAP With Humidification + High Risks of NPC</title>
          <description>ICON Auto CPAP™ with Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
        </group>
        <group group_id="E4">
          <title>APAP Without Humidification + High RIsks of NPC</title>
          <description>ICON Auto CPAP™ without Thermosmart heated tube with patients who are classified to have a high risks (major complaints) of nasopharyngeal problems.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for Ureter Obstruction</sub_title>
                <description>Unrelated event that was resolved with no sequel at the end of the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Georg Nilius</name_or_title>
      <organization>HELIOS-Klinik Ambrock</organization>
      <phone>+492331-9742005</phone>
      <email>klinik-ambrock.pneumo@t-online.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

